Abvc Biopharma (ABVC) Total Current Liabilities (2009 - 2026)
Abvc Biopharma (ABVC) reported Total Current Liabilities of $7.19 million for Q3 2026, up 9.9% from $6.54 million a year earlier and up 26.3% from the prior quarter.
Abvc Biopharma (ABVC) Total Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma posted Total Current Liabilities of $6.92 million, up 5.6% from FY2024.
- Total Current Liabilities has increased for four consecutive years, with a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- By year, Total Current Liabilities came in at $6.56 million in FY2024 (+7.5%), $6.1 million in FY2023 (+10.1%), $5.54 million in FY2022 (+50.1%) and $3.69 million in FY2021 (-23.8%).
- The Q3 2026 figure ranks as the highest quarterly Total Current Liabilities since Q2 2020.
- Year over year, Total Current Liabilities gained in six of the last eight quarters, with growth averaging 1.1%.
- The high point for year-over-year Total Current Liabilities in five years was Q2 2023 (growth of 58.3%); the low point was Q4 2021 (a decline of 23.8%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $5.69 million (Q2 2026), $5.39 million (Q1 2026) and $6.92 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 47.00 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 55.46 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 43.10 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 28.80 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -31.27 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 23.23 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 12.00 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 31.73 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 7.19 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.19 Mn |
| Jun 30, 2026 | 5.69 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | 6.92 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 6.53 Mn |
| Mar 31, 2025 | 6.73 Mn |
| Dec 31, 2024 | 6.56 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | 6.25 Mn |
| Mar 31, 2024 | 6.18 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 5.36 Mn |
| Jun 30, 2023 | 5.77 Mn |
| Mar 31, 2023 | 5.07 Mn |
| Dec 31, 2022 | 5.54 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Jun 30, 2022 | 3.65 Mn |
| Mar 31, 2022 | 3.66 Mn |
| Dec 31, 2021 | 3.69 Mn |
Abvc Biopharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ABVC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();